Analysis of Epstein-Barr virus gene polymorphisms in normal donors and in virus-associated tumors from different geographic locations - PubMed (original) (raw)
. 1996 Nov 1;88(9):3491-501.
Affiliations
- PMID: 8896415
Free article
Analysis of Epstein-Barr virus gene polymorphisms in normal donors and in virus-associated tumors from different geographic locations
F Khanim et al. Blood. 1996.
Free article
Abstract
While Epstein-Barr virus (EBV) infection is associated with the development of certain lymphoid and epithelial tumors, the role of the virus in the pathogenesis of these malignancies remains unknown. It has been suggested that EBV strain variation may contribute to tumor development. Two major strains of EBV, type 1 and type 2, have been identified on the basis of genetic polymorphisms and other minor genetic variations give rise to distinct EBV isolates. We analyzed EBV strain variation in healthy individuals and compared them with EBV isolates present in lymphoid and epithelial neoplasms from the same geographic regions. In particular, the incidence of the 30-bp latent membrane protein (LMP1) gene deletion, recently implicated in the development of more aggressive forms of virus-positive lymphomas and Hodgkin's disease [HD], was examined in the normal population. While a preferential association of the LMP1 deletion with the type 2 strain of EBV was observed, there was no increased incidence of virus isolates carrying this deletion in HD, Burkitt's lymphoma, or virus-associated carcinomas compared with the appropriate normal population. A polymorphism in the BamHI F region of the EBV genome, previously identified in Chinese populations, was found at increased incidence in European HD biopsies. Overall, we found that most of the EBV gene polymorphisms detected in EBV isolates from healthy virus carriers occurred with similar frequency in virus-associated tumors from the same geographical region.
Similar articles
- Epstein--Barr virus gene polymorphisms in Chinese Hodgkin's disease cases and healthy donors: identification of three distinct virus variants.
Zhou XG, Sandvej K, Li PJ, Ji XL, Yan QH, Zhang XP, Da JP, Hamilton-Dutoit SJ. Zhou XG, et al. J Gen Virol. 2001 May;82(Pt 5):1157-1167. doi: 10.1099/0022-1317-82-5-1157. J Gen Virol. 2001. PMID: 11297690 - Epstein-Barr virus latency: LMP2, a regulator or means for Epstein-Barr virus persistence?
Longnecker R. Longnecker R. Adv Cancer Res. 2000;79:175-200. doi: 10.1016/s0065-230x(00)79006-3. Adv Cancer Res. 2000. PMID: 10818681 Review. - Epstein-Barr virus as an agent of haematological disease.
Tosato G, Taga K, Angiolillo AL, Sgadari C. Tosato G, et al. Baillieres Clin Haematol. 1995 Mar;8(1):165-99. doi: 10.1016/s0950-3536(05)80237-9. Baillieres Clin Haematol. 1995. PMID: 7663046 Review.
Cited by
- Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer.
Bollard CM, Gottschalk S, Leen AM, Weiss H, Straathof KC, Carrum G, Khalil M, Wu MF, Huls MH, Chang CC, Gresik MV, Gee AP, Brenner MK, Rooney CM, Heslop HE. Bollard CM, et al. Blood. 2007 Oct 15;110(8):2838-45. doi: 10.1182/blood-2007-05-091280. Epub 2007 Jul 3. Blood. 2007. PMID: 17609424 Free PMC article. Clinical Trial. - Hodgkin's disease and the Epstein-Barr virus.
Flavell KJ, Murray PG. Flavell KJ, et al. Mol Pathol. 2000 Oct;53(5):262-9. doi: 10.1136/mp.53.5.262. Mol Pathol. 2000. PMID: 11091850 Free PMC article. Review. - Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma.
Kapatai G, Murray P. Kapatai G, et al. J Clin Pathol. 2007 Dec;60(12):1342-9. doi: 10.1136/jcp.2007.050146. J Clin Pathol. 2007. PMID: 18042690 Free PMC article. Review. - Epstein-Barr virus genetic variation in Vietnamese patients with nasopharyngeal carcinoma: full-length analysis of LMP1.
Nguyen-Van D, Ernberg I, Phan-Thi Phi P, Tran-Thi C, Hu L. Nguyen-Van D, et al. Virus Genes. 2008 Oct;37(2):273-81. doi: 10.1007/s11262-008-0262-9. Epub 2008 Jul 29. Virus Genes. 2008. PMID: 18663567 - Epstein-Barr Virus Infection in Gastric Remnant Carcinoma and Recurrent Gastric Carcinoma in Qingdao of Northern China.
Liu S, Zhao Z, Han L, Liu S, Luo B. Liu S, et al. PLoS One. 2016 Feb 9;11(2):e0148342. doi: 10.1371/journal.pone.0148342. eCollection 2016. PLoS One. 2016. PMID: 26859565 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources